Literature DB >> 8958310

Histological features do not define NSAID-induced gastritis.

H M El-Zimaity1, R M Genta, D Y Graham.   

Abstract

Nonsteroidal anti-inflammatory drug (NSAID) use is a common cause of peptic ulcer. This study investigated the nature, frequency, and topographic distribution of histological abnormalities of the gastric mucosa associated with chronic NSAID use. A set of 3 to 11 mapped gastric biopsy specimens were obtained from 108 chronic users of NSAIDs and 61 controls. Each specimen was graded from 0 to 3 for each of the following features: foveolar hyperplasia, smooth muscle fibers, edema, neutrophils, intestinal metaplasia, eosinophils, mononuclear cells, mucosal hemorrhage, atrophy, and Helicobacter pylori. We found that foveolar hyperplasia, considered one of the characteristic features of chemical gastropathy, was absent in 66% of NSAID users. Foveolar hyperplasia was present in 37 NSAID users (34%) and in 10 controls (18%); prominent smooth muscle fibers were found in 51 NSAID users (47%) and 10 of the controls (16%). Concurrent H pylori gastritis obscured the histopathologic changes of NSAID use. All other parameters, including H pylori infection rate (57% v 51%) were similar in NSAID users and controls. We conclude that the histological features characteristic of NSAID users were present only in a subset of patients. No single histological feature can be used to characterize or diagnose chemical gastropathy and no simple set of diagnostic criteria can be applied for this purpose.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8958310     DOI: 10.1016/s0046-8177(96)90349-4

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  8 in total

1.  Differences in biological features of gastric dysplasia, indefinite dysplasia, reactive hyperplasia and discriminant analysis of these lesions.

Authors:  Bin Dong; Yu-Quan Xie; Ke Chen; Tao Wang; Wei Tang; Wei-Cheng You; Ji-You Li
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

Review 2.  Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.

Authors:  R La Corte; M Caselli; G Castellino; G Bajocchi; F Trotta
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

3.  Foveolar hyperplasia at the gastric cardia: prevalence and associations.

Authors:  M Voutilainen; M Juhola; M Färkkilä; P Sipponen
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

4.  The histopathology of non-steroidal anti-inflammatory drug induced gastroduodenal damage: correlation with Helicobacter pylori, ulcers, and haemorrhagic events.

Authors:  M Frezza; N Gorji; M Melato
Journal:  J Clin Pathol       Date:  2001-07       Impact factor: 3.411

5.  Atypical histiocytic infiltration simulating diffuse-type carcinoma in a gastric ulcer due to non-steroidal anti-inflammatory drugs.

Authors:  Julián Arista-Nasr; Juan Nuncio; Braulio Martinez
Journal:  Pathol Oncol Res       Date:  2003-02-11       Impact factor: 3.201

6.  Proliferative epithelial changes in ectopic gastric mucosa of Meckel's diverticula.

Authors:  G Cserni
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

Review 7.  The differential diagnosis of Helicobacter pylori negative gastritis.

Authors:  Hala El-Zimaity; Won-Tak Choi; Gregory Y Lauwers; Robert Riddell
Journal:  Virchows Arch       Date:  2018-09-25       Impact factor: 4.064

8.  Rebamipide does not protect against naproxen-induced gastric damage: a randomized double-blind controlled trial.

Authors:  Thiago Gagliano-Jucá; Ronilson A Moreno; Tiago Zaminelli; Mauro Napolitano; Antônio Frederico N Magalhães; Aloísio Carvalhaes; Miriam S Trevisan; John L Wallace; Gilberto De Nucci
Journal:  BMC Gastroenterol       Date:  2016-06-04       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.